Bill Gates AI Drug Discovery Shouldn't need to say much more I think bottom is in GRI 2022
$SDGR recovered from its low range support with a confirmation of Bullish Reversal Hammer Candlestick on 12th November 2020, also trading above its 50DMA in 4 months. The subsequent rally have also played out a Bullish Double Bottom chart pattern breakout on 23rd November 2020, defining a mid term trend channel during the run up. At the current junction,...
NASDAQ:SDGR Our proprietary alerts are telling us that we should see a rebound up to $98.90, also a signal at $93.46 I'm in and ready to buy more options on any dips. Let's go! I'm pumped about this one.
3 Rising Valleys Breakout from initial swing high followed by a retracement to the PivotPoint/14EMA giving us a Southern Doji Bullish Continuation followed by another long wick rejection of the PivotPoint/14EMA. 3 Rising Valleys Long Entry: 42.15 Price Target: 65.84 Stop: 35.85 Southern Doji Bullish Continuation Entry: 53.52 Price Target: 63.63 Stop: 49.72
Recent IPO Schrödinger extends its existing collaboration with AstraZeneca, $AZN, aimed at enhancing the former's Free Energy Perturbation technology for the optimization of key properties of biologics, particularly binding affinity. As technically, it is rising and needs to break the trendlines and hold above $45.
the most disruptive software platform to ever hit the pharmaceutical industry, which also happens to be backed by the world’s most sophisticated investors, has just gone public. Rare disruptive company backed by Bill Gates and D E Shaw Invested 10000 dollars and will add up along the way Exited journey